Q&A with Joshua Eisenberg, MD
Aug 9, 2022
Get to know Dr. Joshua Eisenberg, our newest attending physician in the Division of Gastroenterology, Hepatology and Nutrition.
Osteochondroma
<p>Osteochondroma is the most common benign bone tumor in children. Because an osteochondroma often displays no symptoms, the tumor may only be discovered when a child notices a bump, or reports pain. For some children, the osteochondroma may never be discovered.</p>
Endocrinology, GI on the Move in Voorhees, NJ
Aug 9, 2022
Appointments with Endocrinology and Gastroenterology will each be consolidated in one of CHOP’s Voorhees, NJ, Specialty Care Centers.
CHOP Researchers Refine Understanding of Fetal Hemoglobin Regulation
Aug 8, 2022
CHOP researchers have discovered a new part of the regulatory cascade responsible for silencing fetal hemoglobin in adult cells.
CHOP Helps Develop Platform to Speed Up Drug Development for Kids with Cancer
Aug 4, 2022
CHOP has helped launch NCI-backed “Molecular Targets Platform” to streamline and catalyze drug development by harmonizing data about pediatric cancer targets and pathways.
Children’s Hospital of Philadelphia Receives $400,000 Grant from American Heart Association to Study Hormones Related to Cardiovascular Disease and Metabolic Health
Aug 4, 2022
Aligned with CHOP and AHA’s shared mission to improve cardiac care, grant supports research aiming to discover new hormones secreted from the heart.
Children’s Hospital of Philadelphia Appoints New Chief of Critical Care Medicine
Aug 3, 2022
Robert Sutton, MD, will fulfill leadership role within the Department of Anesthesiology and Critical Care Medicine.
Study Finds Newly Formed “Immature” Neurons Appear in Brain Throughout Lifespan
Aug 2, 2022
CHOP neurosurgeons collaborated with researchers from the University of Pennsylvania School of Medicine to confirm the presence of these neurons from birth through age 92.
CHOP-led Study Finds Daycare Linked to Increased Complications in Preterm Children with Chronic Lung Disease
Jul 26, 2022
Researchers found daycare attendance was associated with increased emergency department visits, steroid use, and chronic respiratory symptoms in preterm children with chronic lung disease.
FDA Approves Drug for Rare Cancer
Jul 25, 2022
CHOP played an instrumental role in leading one of two clinical trials that led to the approval of Xalkori® for unresectable, recurrent, or refractory ALK-positive IMT.
Community Impact Welcomes New CHOP Cares Community Advisory Board Chair
Jul 22, 2022
In April, the Office of Community Impact officially welcomed John William Chin as the new CHOP Cares Community Advisory Board Chair. He has served on CHOP Cares Community Advisory Board for the past three years.